“I like everyone at the surgery office. Everyone was attentive and explained in detail. Doctor was experienced and made me aware of everything. Thanks 😊.”
Eylea for Retinal Disease: Your Guide to Anti-VEGF Injection Therapy
The Injection Experience
Many patients feel anxious before their first eye injection. Understanding each step of the process can help ease those concerns. The procedure is brief, well-tolerated by most patients, and takes place entirely in the office.
Before the injection, your retina specialist will apply anesthetic drops or a small amount of numbing medication to your eye. The surface of the eye is then cleaned with an antiseptic solution to reduce the risk of infection. You may notice a cool or slightly wet sensation during this step.
The injection itself takes only a few seconds, though the full appointment from preparation to completion typically lasts five to ten minutes. Your retina specialist uses a very thin needle to deliver the medication through the white part of the eye into the vitreous cavity, the clear gel-like space inside the eye.
Most patients feel pressure during the injection rather than sharp pain. The numbing medication makes the procedure far more comfortable than many expect.
It is normal to feel mild discomfort, grittiness, or temporary blurring after an injection. Some patients notice small floaters for a short time. These effects typically resolve within a few hours to a day.
Your retina specialist may check your eye pressure before you leave the office. For many patients, discomfort tends to decrease with each subsequent treatment as they become more familiar with the process.
Treatment Schedules and Dosing
Eylea is not a one-time treatment. It requires a planned schedule of injections to be effective. Your retina specialist will tailor this schedule to your condition and how your retina responds over time.
Most patients begin with a series of monthly injections called the loading phase. For wet AMD, this typically means one injection every four weeks for the first three months. For diabetic macular edema, monthly loading doses may continue for up to five months. This initial phase helps establish an effective level of medication in the eye.
After the loading phase, your retina specialist will determine a maintenance schedule based on how your retina is responding. Standard-dose Eylea is typically given every four to eight weeks during maintenance. Imaging tests performed at each visit help guide these decisions. Some patients are able to gradually extend the time between injections as their condition stabilizes.
Eylea HD is a higher-dose formulation of aflibercept (8 mg per injection) that received FDA approval for wet AMD, diabetic macular edema, and diabetic retinopathy, and later for retinal vein occlusion. After a loading phase, Eylea HD may allow dosing intervals of 8 to 16 weeks for eligible patients.
For many people, this means fewer visits and fewer injections per year while still achieving the same level of vision protection. Your retina specialist can discuss whether Eylea HD is a suitable option for your situation.
Benefits, Risks, and Safety
Like any medical treatment, Eylea carries both meaningful benefits and a range of possible side effects. Understanding both helps you make informed decisions alongside your retina specialist.
The primary goal of anti-VEGF therapy is to stabilize the retina and prevent further vision loss. Many patients also experience meaningful improvements in their vision, including gains in their ability to read, recognize faces, and perform everyday tasks. Clinical trials have shown that the majority of patients maintain their vision over time with consistent treatment.
Results vary depending on the condition being treated, how early treatment begins, and how regularly injections are maintained. Early treatment generally leads to better long-term outcomes.
The most common side effects after an Eylea injection are mild and temporary. These include redness of the eye, a gritty or foreign-body sensation, mild discomfort, floaters, and temporary blurred vision. Most of these effects resolve on their own within a few days.
Serious complications from intravitreal (into the eye) injections are uncommon but can occur. These include infection inside the eye (a condition called endophthalmitis), retinal detachment, elevated eye pressure, and bleeding within the eye. There is also a very small risk of a blood clot event in rare cases.
If you experience sudden vision loss, severe or worsening eye pain, rapidly increasing redness, or a shadow or curtain across your vision after an injection, seek emergency care immediately. These symptoms require prompt evaluation.
Eylea Compared to Other Anti-VEGF Options
Eylea is one of several anti-VEGF medications available for retinal disease. Your retina specialist will consider several factors when selecting the most appropriate treatment for your specific condition.
The anti-VEGF class includes Avastin (bevacizumab), which is commonly used off-label for eye conditions, Lucentis (ranibizumab), Eylea (aflibercept), and Vabysmo (faricimab). Each blocks VEGF, but they differ in their molecular design, dosing intervals, and FDA-approved uses. Vabysmo, for example, targets both VEGF and a second protein called angiopoietin-2, which plays a role in blood vessel stability.
Multiple aflibercept biosimilars have also been approved in recent years. Biosimilars are highly similar versions of an approved medication and may offer additional treatment options for patients.
There is no single right answer when choosing an anti-VEGF medication. Your retina specialist considers your specific diagnosis, your retina's response to prior treatment, the dosing schedule that fits your lifestyle, and other individual factors.
Switching medications is common and can be appropriate if your current treatment is not producing the desired results. Open communication with your retina specialist about your response and any concerns is an important part of long-term care.
What to Expect After Each Injection
Knowing how to care for your eye after each appointment and recognizing symptoms that need prompt attention will help you stay safe and get the most from your treatment.
You can typically return to most normal daily activities the same day as your injection. Your vision may be temporarily blurry due to the numbing drops and the procedure itself. Avoid rubbing your eye for the remainder of the day. Your retina specialist may prescribe antibiotic eye drops to use for a few days after each treatment.
Regular follow-up appointments are an essential part of anti-VEGF therapy. At each visit, your retina specialist will typically perform imaging tests, including optical coherence tomography (OCT), which creates detailed cross-sectional images of the retina, to check for any remaining fluid or swelling. These results guide decisions about your next injection and any adjustments to your treatment plan.
Certain symptoms after an injection should never be ignored. Contact your retina specialist or go to an emergency room right away if you notice sudden vision loss, severe or worsening eye pain, rapidly spreading redness, a significant increase in floaters, flashes of light, or a dark shadow or curtain across any part of your vision. These could be signs of a serious complication that requires urgent treatment.
Frequently Asked Questions
Here are answers to questions our patients commonly ask about Eylea and anti-VEGF injection therapy.
This depends on your specific condition and how well your retina responds to treatment. Many retinal diseases are chronic and require long-term management, which may mean injections for months or years. Your retina specialist will work with you to find the safest, longest interval between injections that still keeps your retina stable. Some patients on Eylea HD can go 12 to 16 weeks between treatments, which significantly reduces the annual number of office visits.
Eylea can improve vision for some patients, particularly when treatment starts before significant retinal damage has occurred. However, cells in the retina that have been permanently damaged are not able to fully regenerate, so there are limits to how much vision can be recovered. The earlier treatment begins, the better the chance of preserving existing vision and, in some cases, achieving meaningful improvement. Your retina specialist can give you a realistic sense of what to expect based on your current retinal health.
Delaying an injection can allow fluid and swelling to return to the retina, which may cause your vision to worsen. If you need to reschedule, contact your retina specialist as soon as possible rather than waiting until your next scheduled visit. Staying as close to your recommended schedule as possible gives you the best chance of maintaining stable vision over time.
Eylea is approved for wet AMD, which is the type characterized by abnormal blood vessel growth and fluid leakage beneath the retina. It directly targets the VEGF protein driving those changes. Dry AMD and its advanced form, geographic atrophy (gradual loss of retinal cells), involve a different disease process and require different treatments. Complement inhibitors such as Izervay (avacincaptad pegol) are approved for geographic atrophy specifically. Your retina specialist can explain which treatments apply to your type and stage of AMD.
At each follow-up visit, your retina specialist will review your vision and perform retinal imaging, typically OCT, to look for fluid or structural changes in the macula. This imaging allows for precise, objective tracking of how your retina is responding visit to visit. Some patients also benefit from fluorescein angiography or wide-field imaging when more detailed evaluation is needed. If the current treatment is not producing adequate results, your retina specialist can adjust the medication, dosing frequency, or treatment approach accordingly.
While anti-VEGF injections are the primary treatment for conditions like wet AMD and diabetic macular edema, certain lifestyle habits can support overall retinal health. Managing blood sugar and blood pressure is especially important for patients with diabetic eye disease. Nutritional supplements formulated for macular health, such as those following the AREDS2 formula, may also be appropriate for certain patients with AMD. Ask your retina specialist whether any supplements or lifestyle modifications are relevant to your specific situation.
Schedule a Consultation at Atlantic Retina Center
If you have been diagnosed with a retinal condition or are experiencing changes in your vision, our team at Atlantic Retina Center is here to help. We are a single-specialty retinal practice, which means every member of our team is focused exclusively on the health of your retina, vitreous, and macula. Our fellowship-trained, board-certified retina specialists bring deep expertise and a genuine commitment to protecting your vision for the long term. We welcome patients from across the Delmarva peninsula and look forward to partnering with you in your care.